Skip to main navigation Skip to search Skip to main content

A phase I clinical trial on combined (neo-)adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma (NEO-GLITIPNI).

Activity: Talk or presentation › Talk or presentation at a conference

Period31 May 2025
Event titleASCO Annual meeting 2025: Driving Knowledge to Action Building a Better Future
Event typeConference
LocationcHICAGO, United States, IllinoisShow on map
Degree of RecognitionInternational